APO Research
Talk to an analyst

APO RESEARCH · REPORT

Commercial Drug Procurement

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Commercial Drug Procurement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

3 March 2026198 pages

Choose your research edition.

Industry ResearchCommercial Drug Procurement Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Commercial Drug Procurement Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Commercial Drug Procurement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Commercial Drug Procurement Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Commercial Drug Procurement Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Commercial Drug Procurement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Commercial Drug Procurement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Commercial Drug Procurement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Commercial Drug Procurement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Commercial Drug Procurement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Commercial Drug Procurement include Viseven, Bionical Emas, Almac, BMclinical, Myonex, McKesson, Parexel, Patheon and Clinigen, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Commercial Drug Procurement market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Commercial Drug Procurement and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Commercial Drug Procurement revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Commercial Drug Procurement market size, projected growth trends, production technologies, key applications, and end-use industries.

Commercial Drug Procurement Segment by Company

Viseven

Bionical Emas

Almac

BMclinical

Myonex

McKesson

Parexel

Patheon

Clinigen

UPS Healthcare

Catalent

Endpoint Clinical

Signant Health

YPrime

Commercial Drug Procurement Segment by Type

Tender

Direct Procurement

Competitive Negotiation

Others

Commercial Drug Procurement Segment by Application

Life Sciences

Clinical Trials

Others

Commercial Drug Procurement Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Commercial Drug Procurement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Commercial Drug Procurement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Commercial Drug Procurement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Commercial Drug Procurement in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Commercial Drug Procurement industry.

Chapter 3: Detailed analysis of Commercial Drug Procurement companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Commercial Drug Procurementrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Commercial Drug Procurement Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Tender Table 3. Key Players of Direct Procurement Table 4. Key Players of Competitive Negotiation Table 3. Key Players of Others Table 4. Global Commercial Drug Procurement Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Life Sciences Table 6. Key Players of Clinical Trials Table 7. Key Players of Others Table 8. Global Commercial Drug Procurement Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Commercial Drug Procurement Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Commercial Drug Procurement Market Share by Region (2021-2026) Table 11. Global Commercial Drug Procurement Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Commercial Drug Procurement Market Share by Region (2027-2032) Table 13. Commercial Drug Procurement Industry Trends Table 14. Commercial Drug Procurement Industry Drivers Table 15. Commercial Drug Procurement Industry Opportunities and Challenges Table 16. Commercial Drug Procurement Industry Restraints Table 17. Global Commercial Drug Procurement Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Commercial Drug Procurement Revenue Market Share by Company (2021-2026) Table 19. Global Commercial Drug Procurement Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Commercial Drug Procurement Key Company Head Office and Area Served Table 21. Global Commercial Drug Procurement Company, Product Type & Application Table 22. Global Commercial Drug Procurement Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Commercial Drug Procurement by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Commercial Drug Procurement Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Commercial Drug Procurement Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Commercial Drug Procurement Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Commercial Drug Procurement Revenue Market Share by Type (2021-2026) Table 29. Global Commercial Drug Procurement Revenue Market Share by Type (2027-2032) Table 30. Global Commercial Drug Procurement Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Commercial Drug Procurement Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Commercial Drug Procurement Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Commercial Drug Procurement Revenue Market Share by Application (2021-2026) Table 34. Global Commercial Drug Procurement Revenue Market Share by Application (2027-2032) Table 35. Viseven Company Information Table 36. Viseven Business Overview Table 37. Viseven Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Viseven Commercial Drug Procurement Product Portfolio Table 39. Viseven Recent Development Table 40. Bionical Emas Company Information Table 41. Bionical Emas Business Overview Table 42. Bionical Emas Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Bionical Emas Commercial Drug Procurement Product Portfolio Table 44. Bionical Emas Recent Development Table 45. Almac Company Information Table 46. Almac Business Overview Table 47. Almac Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Almac Commercial Drug Procurement Product Portfolio Table 49. Almac Recent Development Table 50. BMclinical Company Information Table 51. BMclinical Business Overview Table 52. BMclinical Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. BMclinical Commercial Drug Procurement Product Portfolio Table 54. BMclinical Recent Development Table 55. Myonex Company Information Table 56. Myonex Business Overview Table 57. Myonex Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Myonex Commercial Drug Procurement Product Portfolio Table 59. Myonex Recent Development Table 60. McKesson Company Information Table 61. McKesson Business Overview Table 62. McKesson Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. McKesson Commercial Drug Procurement Product Portfolio Table 64. McKesson Recent Development Table 65. Parexel Company Information Table 66. Parexel Business Overview Table 67. Parexel Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Parexel Commercial Drug Procurement Product Portfolio Table 69. Parexel Recent Development Table 70. Patheon Company Information Table 71. Patheon Business Overview Table 72. Patheon Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Patheon Commercial Drug Procurement Product Portfolio Table 74. Patheon Recent Development Table 75. Clinigen Company Information Table 76. Clinigen Business Overview Table 77. Clinigen Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Clinigen Commercial Drug Procurement Product Portfolio Table 79. Clinigen Recent Development Table 80. UPS Healthcare Company Information Table 81. UPS Healthcare Business Overview Table 82. UPS Healthcare Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. UPS Healthcare Commercial Drug Procurement Product Portfolio Table 84. UPS Healthcare Recent Development Table 85. Catalent Company Information Table 86. Catalent Business Overview Table 87. Catalent Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Catalent Commercial Drug Procurement Product Portfolio Table 89. Catalent Recent Development Table 90. Endpoint Clinical Company Information Table 91. Endpoint Clinical Business Overview Table 92. Endpoint Clinical Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. Endpoint Clinical Commercial Drug Procurement Product Portfolio Table 94. Endpoint Clinical Recent Development Table 95. Signant Health Company Information Table 96. Signant Health Business Overview Table 97. Signant Health Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. Signant Health Commercial Drug Procurement Product Portfolio Table 99. Signant Health Recent Development Table 100. YPrime Company Information Table 101. YPrime Business Overview Table 102. YPrime Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 103. YPrime Commercial Drug Procurement Product Portfolio Table 104. YPrime Recent Development Table 105. North America Commercial Drug Procurement Market Size by Type (2021-2026) & (US$ Million) Table 106. North America Commercial Drug Procurement Market Size by Type (2027-2032) & (US$ Million) Table 107. North America Commercial Drug Procurement Market Size by Application (2021-2026) & (US$ Million) Table 108. North America Commercial Drug Procurement Market Size by Application (2027-2032) & (US$ Million) Table 109. North America Commercial Drug Procurement Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. North America Commercial Drug Procurement Market Size by Country (2021-2026) Table 111. North America Commercial Drug Procurement Market Size by Country (2027-2032) Table 112. Europe Commercial Drug Procurement Market Size by Type (2021-2026) & (US$ Million) Table 113. Europe Commercial Drug Procurement Market Size by Type (2027-2032) & (US$ Million) Table 114. Europe Commercial Drug Procurement Market Size by Application (2021-2026) & (US$ Million) Table 115. Europe Commercial Drug Procurement Market Size by Application (2027-2032) & (US$ Million) Table 116. Europe Commercial Drug Procurement Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. Europe Commercial Drug Procurement Market Size by Country (2021-2026) Table 118. Europe Commercial Drug Procurement Market Size by Country (2027-2032) Table 119. China Commercial Drug Procurement Market Size by Type (2021-2026) & (US$ Million) Table 120. China Commercial Drug Procurement Market Size by Type (2027-2032) & (US$ Million) Table 121. China Commercial Drug Procurement Market Size by Application (2021-2026) & (US$ Million) Table 122. China Commercial Drug Procurement Market Size by Application (2027-2032) & (US$ Million) Table 123. Asia Commercial Drug Procurement Market Size by Type (2021-2026) & (US$ Million) Table 124. Asia Commercial Drug Procurement Market Size by Type (2027-2032) & (US$ Million) Table 125. Asia Commercial Drug Procurement Market Size by Application (2021-2026) & (US$ Million) Table 126. Asia Commercial Drug Procurement Market Size by Application (2027-2032) & (US$ Million) Table 127. Asia Commercial Drug Procurement Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Asia Commercial Drug Procurement Market Size by Country (2021-2026) Table 129. Asia Commercial Drug Procurement Market Size by Country (2027-2032) Table 130. South America, Middle East & Africa Commercial Drug Procurement Market Size by Type (2021-2026) & (US$ Million) Table 131. South America, Middle East & Africa Commercial Drug Procurement Market Size by Type (2027-2032) & (US$ Million) Table 132. South America, Middle East & Africa Commercial Drug Procurement Market Size by Application (2021-2026) & (US$ Million) Table 133. South America, Middle East & Africa Commercial Drug Procurement Market Size by Application (2027-2032) & (US$ Million) Table 134. South America, Middle East & Africa Commercial Drug Procurement Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 135. South America, Middle East & Africa Commercial Drug Procurement Market Size by Country (2021-2026) Table 136. South America, Middle East & Africa Commercial Drug Procurement Market Size by Country (2027-2032) Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Commercial Drug Procurement Product Image Figure 2. Global Commercial Drug Procurement Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Commercial Drug Procurement Market Share by Type: 2025 VS 2032 Figure 4. Tender Image Figure 5. Direct Procurement Image Figure 6. Competitive Negotiation Image Figure 7. Others Image Figure 8. Global Commercial Drug Procurement Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Commercial Drug Procurement Market Share by Application: 2025 VS 2032 Figure 10. Life Sciences Image Figure 11. Clinical Trials Image Figure 12. Others Image Figure 13. Global Commercial Drug Procurement Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 15. Global Commercial Drug Procurement Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global Commercial Drug Procurement Market Share by Players in 2025 Figure 18. Global Top 5 and 10 Commercial Drug Procurement Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Commercial Drug Procurement Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Commercial Drug Procurement Revenue Market Share by Type (2021-2032) Figure 22. Global Commercial Drug Procurement Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Commercial Drug Procurement Revenue Market Share by Application (2021-2032) Figure 24. North America Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 25. North America Commercial Drug Procurement Market Share by Type (2021-2032) Figure 26. North America Commercial Drug Procurement Market Share by Application (2021-2032) Figure 27. North America Commercial Drug Procurement Market Share by Country (2021-2032) Figure 28. United States Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 29. Canada Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 30. Mexico Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 31. Europe Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 32. Europe Commercial Drug Procurement Market Share by Type (2021-2032) Figure 33. Europe Commercial Drug Procurement Market Share by Application (2021-2032) Figure 34. Europe Commercial Drug Procurement Market Share by Country (2021-2032) Figure 35. Germany Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 36. France Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 37. U.K. Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 38. Italy Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 39. Russia Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 41. China Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 42. China Commercial Drug Procurement Market Share by Type (2021-2032) Figure 43. China Commercial Drug Procurement Market Share by Application (2021-2032) Figure 44. Asia Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 45. Asia Commercial Drug Procurement Market Share by Type (2021-2032) Figure 46. Asia Commercial Drug Procurement Market Share by Application (2021-2032) Figure 47. Asia Commercial Drug Procurement Market Share by Country (2021-2032) Figure 48. Japan Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 49. South Korea Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 52. India Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 53. Australia Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Commercial Drug Procurement Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa Commercial Drug Procurement Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa Commercial Drug Procurement Market Share by Country (2021-2032) Figure 58. Brazil Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 59. South Africa Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 61. Turkey Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 62. Argentina Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 63. UAE Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 64. Egypt Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 65. Chile Commercial Drug Procurement Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Tender
  • Direct Procurement
  • Competitive Negotiation
  • Others
Applications
  • Life Sciences
  • Clinical Trials
  • Others
Companies covered
  • Viseven
  • Bionical Emas
  • Almac
  • BMclinical
  • Myonex
  • McKesson
  • Parexel
  • Patheon
  • Clinigen
  • UPS Healthcare
  • Catalent
  • Endpoint Clinical
  • Signant Health
  • YPrime

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Commercial Drug Procurement Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Tender
  5. 1.2.3 Direct Procurement
  6. 1.2.4 Competitive Negotiation
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Commercial Drug Procurement Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Life Sciences
  11. 1.3.3 Clinical Trials
  12. 1.3.4 Others
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global Commercial Drug Procurement Growth Trends by Region
  15. 1.5.1 Global Commercial Drug Procurement Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 Commercial Drug Procurement Market Size by Region (2021-2026)
  17. 1.5.3 Commercial Drug Procurement Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global Commercial Drug Procurement Market Dynamics
  1. 2.1 Commercial Drug Procurement Industry Trends
  2. 2.2 Commercial Drug Procurement Industry Drivers
  3. 2.3 Commercial Drug Procurement Industry Opportunities and Challenges
  4. 2.4 Commercial Drug Procurement Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Commercial Drug Procurement Revenue by Company (2021-2026)
  2. 3.2 Global Commercial Drug Procurement Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Commercial Drug Procurement Key Company Head office and Area Served
  4. 3.4 Global Commercial Drug Procurement Company, Product Type & Application
  5. 3.5 Global Commercial Drug Procurement Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Commercial Drug Procurement Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Commercial Drug Procurement Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Commercial Drug Procurement Tier 1, Tier 2, and Tier 3
4 Commercial Drug Procurement Market by Type
  1. 4.1 Global Commercial Drug Procurement Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Commercial Drug Procurement Market Size by Type (2021-2032)
  3. 4.3 Global Commercial Drug Procurement Market Size Share by Type (2021-2032)
5 Commercial Drug Procurement Market by Application
  1. 5.1 Global Commercial Drug Procurement Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Commercial Drug Procurement Market Size by Application (2021-2032)
  3. 5.3 Global Commercial Drug Procurement Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Viseven
  2. 6.1.1 Viseven Company Information
  3. 6.1.2 Viseven Business Overview
  4. 6.1.3 Viseven Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Viseven Commercial Drug Procurement Product Portfolio
  6. 6.1.5 Viseven Recent Developments
  7. 6.2 Bionical Emas
  8. 6.2.1 Bionical Emas Company Information
  9. 6.2.2 Bionical Emas Business Overview
  10. 6.2.3 Bionical Emas Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Bionical Emas Commercial Drug Procurement Product Portfolio
  12. 6.2.5 Bionical Emas Recent Developments
  13. 6.3 Almac
  14. 6.3.1 Almac Company Information
  15. 6.3.2 Almac Business Overview
  16. 6.3.3 Almac Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Almac Commercial Drug Procurement Product Portfolio
  18. 6.3.5 Almac Recent Developments
  19. 6.4 BMclinical
  20. 6.4.1 BMclinical Company Information
  21. 6.4.2 BMclinical Business Overview
  22. 6.4.3 BMclinical Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 BMclinical Commercial Drug Procurement Product Portfolio
  24. 6.4.5 BMclinical Recent Developments
  25. 6.5 Myonex
  26. 6.5.1 Myonex Company Information
  27. 6.5.2 Myonex Business Overview
  28. 6.5.3 Myonex Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Myonex Commercial Drug Procurement Product Portfolio
  30. 6.5.5 Myonex Recent Developments
  31. 6.6 McKesson
  32. 6.6.1 McKesson Company Information
  33. 6.6.2 McKesson Business Overview
  34. 6.6.3 McKesson Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 McKesson Commercial Drug Procurement Product Portfolio
  36. 6.6.5 McKesson Recent Developments
  37. 6.7 Parexel
  38. 6.7.1 Parexel Company Information
  39. 6.7.2 Parexel Business Overview
  40. 6.7.3 Parexel Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Parexel Commercial Drug Procurement Product Portfolio
  42. 6.7.5 Parexel Recent Developments
  43. 6.8 Patheon
  44. 6.8.1 Patheon Company Information
  45. 6.8.2 Patheon Business Overview
  46. 6.8.3 Patheon Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Patheon Commercial Drug Procurement Product Portfolio
  48. 6.8.5 Patheon Recent Developments
  49. 6.9 Clinigen
  50. 6.9.1 Clinigen Company Information
  51. 6.9.2 Clinigen Business Overview
  52. 6.9.3 Clinigen Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Clinigen Commercial Drug Procurement Product Portfolio
  54. 6.9.5 Clinigen Recent Developments
  55. 6.10 UPS Healthcare
  56. 6.10.1 UPS Healthcare Company Information
  57. 6.10.2 UPS Healthcare Business Overview
  58. 6.10.3 UPS Healthcare Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 UPS Healthcare Commercial Drug Procurement Product Portfolio
  60. 6.10.5 UPS Healthcare Recent Developments
  61. 6.11 Catalent
  62. 6.11.1 Catalent Company Information
  63. 6.11.2 Catalent Business Overview
  64. 6.11.3 Catalent Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Catalent Commercial Drug Procurement Product Portfolio
  66. 6.11.5 Catalent Recent Developments
  67. 6.12 Endpoint Clinical
  68. 6.12.1 Endpoint Clinical Company Information
  69. 6.12.2 Endpoint Clinical Business Overview
  70. 6.12.3 Endpoint Clinical Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 Endpoint Clinical Commercial Drug Procurement Product Portfolio
  72. 6.12.5 Endpoint Clinical Recent Developments
  73. 6.13 Signant Health
  74. 6.13.1 Signant Health Company Information
  75. 6.13.2 Signant Health Business Overview
  76. 6.13.3 Signant Health Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 Signant Health Commercial Drug Procurement Product Portfolio
  78. 6.13.5 Signant Health Recent Developments
  79. 6.14 YPrime
  80. 6.14.1 YPrime Company Information
  81. 6.14.2 YPrime Business Overview
  82. 6.14.3 YPrime Commercial Drug Procurement Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 YPrime Commercial Drug Procurement Product Portfolio
  84. 6.14.5 YPrime Recent Developments
7 North America
  1. 7.1 North America Commercial Drug Procurement Market Size (2021-2032)
  2. 7.2 North America Commercial Drug Procurement Market Size by Type
  3. 7.2.1 North America Commercial Drug Procurement Market Size by Type (2021-2026)
  4. 7.2.2 North America Commercial Drug Procurement Market Size by Type (2027-2032)
  5. 7.2.3 North America Commercial Drug Procurement Market Share by Type (2021-2032)
  6. 7.3 North America Commercial Drug Procurement Market Size by Application
  7. 7.3.1 North America Commercial Drug Procurement Market Size by Application (2021-2026)
  8. 7.3.2 North America Commercial Drug Procurement Market Size by Application (2027-2032)
  9. 7.3.3 North America Commercial Drug Procurement Market Share by Application (2021-2032)
  10. 7.4 North America Commercial Drug Procurement Market Size by Country
  11. 7.4.1 North America Commercial Drug Procurement Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Commercial Drug Procurement Market Size by Country (2021-2026)
  13. 7.4.3 North America Commercial Drug Procurement Market Size by Country (2027-2032)
  14. 7.4.4 North America Commercial Drug Procurement Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Commercial Drug Procurement Market Size (2021-2032)
  2. 8.2 Europe Commercial Drug Procurement Market Size by Type
  3. 8.2.1 Europe Commercial Drug Procurement Market Size by Type (2021-2026)
  4. 8.2.2 Europe Commercial Drug Procurement Market Size by Type (2027-2032)
  5. 8.2.3 Europe Commercial Drug Procurement Market Share by Type (2021-2032)
  6. 8.3 Europe Commercial Drug Procurement Market Size by Application
  7. 8.3.1 Europe Commercial Drug Procurement Market Size by Application (2021-2026)
  8. 8.3.2 Europe Commercial Drug Procurement Market Size by Application (2027-2032)
  9. 8.3.3 Europe Commercial Drug Procurement Market Share by Application (2021-2032)
  10. 8.4 Europe Commercial Drug Procurement Market Size by Country
  11. 8.4.1 Europe Commercial Drug Procurement Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Commercial Drug Procurement Market Size by Country (2021-2026)
  13. 8.4.3 Europe Commercial Drug Procurement Market Size by Country (2027-2032)
  14. 8.4.4 Europe Commercial Drug Procurement Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Commercial Drug Procurement Market Size (2021-2032)
  2. 9.2 China Commercial Drug Procurement Market Size by Type
  3. 9.2.1 China Commercial Drug Procurement Market Size by Type (2021-2026)
  4. 9.2.2 China Commercial Drug Procurement Market Size by Type (2027-2032)
  5. 9.2.3 China Commercial Drug Procurement Market Share by Type (2021-2032)
  6. 9.3 China Commercial Drug Procurement Market Size by Application
  7. 9.3.1 China Commercial Drug Procurement Market Size by Application (2021-2026)
  8. 9.3.2 China Commercial Drug Procurement Market Size by Application (2027-2032)
  9. 9.3.3 China Commercial Drug Procurement Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Commercial Drug Procurement Market Size (2021-2032)
  2. 10.2 Asia Commercial Drug Procurement Market Size by Type
  3. 10.2.1 Asia Commercial Drug Procurement Market Size by Type (2021-2026)
  4. 10.2.2 Asia Commercial Drug Procurement Market Size by Type (2027-2032)
  5. 10.2.3 Asia Commercial Drug Procurement Market Share by Type (2021-2032)
  6. 10.3 Asia Commercial Drug Procurement Market Size by Application
  7. 10.3.1 Asia Commercial Drug Procurement Market Size by Application (2021-2026)
  8. 10.3.2 Asia Commercial Drug Procurement Market Size by Application (2027-2032)
  9. 10.3.3 Asia Commercial Drug Procurement Market Share by Application (2021-2032)
  10. 10.4 Asia Commercial Drug Procurement Market Size by Country
  11. 10.4.1 Asia Commercial Drug Procurement Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Commercial Drug Procurement Market Size by Country (2021-2026)
  13. 10.4.3 Asia Commercial Drug Procurement Market Size by Country (2027-2032)
  14. 10.4.4 Asia Commercial Drug Procurement Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Commercial Drug Procurement Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Commercial Drug Procurement Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Commercial Drug Procurement Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Commercial Drug Procurement Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Commercial Drug Procurement Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Commercial Drug Procurement Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Commercial Drug Procurement Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Commercial Drug Procurement Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Commercial Drug Procurement Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Commercial Drug Procurement Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Commercial Drug Procurement Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Commercial Drug Procurement Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Commercial Drug Procurement Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Commercial Drug Procurement Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst